HUP9900659A2 - Alendronát alkalmazása oszteoporózis megelőzésére - Google Patents

Alendronát alkalmazása oszteoporózis megelőzésére

Info

Publication number
HUP9900659A2
HUP9900659A2 HU9900659A HUP9900659A HUP9900659A2 HU P9900659 A2 HUP9900659 A2 HU P9900659A2 HU 9900659 A HU9900659 A HU 9900659A HU P9900659 A HUP9900659 A HU P9900659A HU P9900659 A2 HUP9900659 A2 HU P9900659A2
Authority
HU
Hungary
Prior art keywords
alendronate
prevention
osteoporosis
hydroxybutylidene
bisphosphonate
Prior art date
Application number
HU9900659A
Other languages
English (en)
Inventor
Ashley J. Yates
Original Assignee
Merck & Co., Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co., Inc. filed Critical Merck & Co., Inc.
Publication of HUP9900659A2 publication Critical patent/HUP9900659A2/hu
Publication of HUP9900659A3 publication Critical patent/HUP9900659A3/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A találmány tárgya alendronát, azaz 4-amino-1-hidroxi-butilidén-1,1-biszfoszfonát alkalmazása a nők korai posztmenopauzálisoszteoporózisának megelőzését szolgáló gyógyszer előállítására. Ó
HU9900659A 1995-06-02 1996-05-29 Use of alendronate for prevention of osteoporosis HUP9900659A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45819595A 1995-06-02 1995-06-02
PCT/US1996/007912 WO1996038156A1 (en) 1995-06-02 1996-05-29 Use of alendronate for the prevention of osteoporosis

Publications (2)

Publication Number Publication Date
HUP9900659A2 true HUP9900659A2 (hu) 2001-04-28
HUP9900659A3 HUP9900659A3 (en) 2002-12-28

Family

ID=23819759

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9900659A HUP9900659A3 (en) 1995-06-02 1996-05-29 Use of alendronate for prevention of osteoporosis

Country Status (21)

Country Link
EP (1) EP0828496A1 (hu)
JP (1) JPH10506648A (hu)
KR (1) KR19990022436A (hu)
CN (1) CN1192685A (hu)
AU (1) AU709196B2 (hu)
BG (1) BG63103B1 (hu)
BR (1) BR9609020A (hu)
CA (1) CA2222318A1 (hu)
CZ (1) CZ381197A3 (hu)
EA (1) EA000677B1 (hu)
EE (1) EE03306B1 (hu)
HU (1) HUP9900659A3 (hu)
IL (1) IL118422A0 (hu)
IS (1) IS4617A (hu)
NO (1) NO975527L (hu)
NZ (1) NZ308935A (hu)
PL (1) PL323669A1 (hu)
SK (1) SK159597A3 (hu)
TR (1) TR199701482T1 (hu)
WO (1) WO1996038156A1 (hu)
ZA (1) ZA964465B (hu)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
SE9901272D0 (sv) * 1999-04-09 1999-04-09 Astra Ab New improved formulation
KR100317935B1 (ko) * 1999-10-20 2001-12-22 유승필 대사성 골질환 치료용 약제조성물 및 이의 제조방법
BR0209360A (pt) * 2001-05-02 2004-06-08 Novartis Ag Método de administração de bisfosfonatos por inalação no tratamento ou prevenção de reabsorção óssea e osteoporose
JP2010043119A (ja) * 2009-10-16 2010-02-25 Gador Sa 骨の代謝病の予防および/または治療のための組成物、その組成物の調製方法およびその使用
KR102472749B1 (ko) * 2022-01-18 2022-12-02 주식회사 위엔씨 유해가스제거 및 항균탈취기능을 함유한 흡착소재 제조방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5366965A (en) * 1993-01-29 1994-11-22 Boehringer Mannheim Gmbh Regimen for treatment or prophylaxis of osteoporosis
US5462932A (en) * 1994-05-17 1995-10-31 Merck & Co., Inc. Oral liquid alendronate formulations

Also Published As

Publication number Publication date
PL323669A1 (en) 1998-04-14
IS4617A (is) 1997-11-19
BG63103B1 (bg) 2001-04-30
EA199700449A1 (ru) 1998-06-25
JPH10506648A (ja) 1998-06-30
CN1192685A (zh) 1998-09-09
BG102060A (en) 1998-07-31
AU709196B2 (en) 1999-08-26
CZ381197A3 (cs) 1998-06-17
WO1996038156A1 (en) 1996-12-05
SK159597A3 (en) 1998-06-03
NO975527D0 (no) 1997-12-01
TR199701482T1 (xx) 1998-03-21
CA2222318A1 (en) 1996-12-05
HUP9900659A3 (en) 2002-12-28
EP0828496A1 (en) 1998-03-18
IL118422A0 (en) 1996-09-12
BR9609020A (pt) 1999-07-06
ZA964465B (en) 1996-12-11
EA000677B1 (ru) 2000-02-28
NZ308935A (en) 2000-07-28
EE03306B1 (et) 2000-12-15
AU5882496A (en) 1996-12-18
KR19990022436A (ko) 1999-03-25
NO975527L (no) 1997-12-01

Similar Documents

Publication Publication Date Title
MX9800401A (es) Sistema transcorneal de liberacion de medicamentos.
NO20000935D0 (no) Fremgangsmåte for inhibering av komplementaktivering via den alternative reaksjonsvei
BG101901A (en) 2-methyl-thieno-benzodiazepine formulation for oral application
DK0859889T3 (da) Slidenhed til gravekanten på en graveindretning
FI960851A0 (fi) Menetelmä N-amino-1-hydroksi-alkylideeni-1,1-bisfosfonihappojen valmistamiseksi
DK0756484T3 (da) Vådgranuleringsformulering til diphosphonsyrer
HUP9900659A2 (hu) Alendronát alkalmazása oszteoporózis megelőzésére
CA2024694A1 (en) Acyloxymethyl esters of bisphosphonic acids as bone resorption inhibitors
AU1160700A (en) Ppar gamma ligands
BG103649A (en) Method for the preparation of eprosartan
AU6148396A (en) Disodium alendronate formulations
BG103650A (en) Method for the preparation of eprosartan
ZA200110450B (en) Oral preparations of etidronate disodium.
FR2710518B1 (fr) Ensemble de mise en place d'une prothèse formée d'un tissu souple.
MX9706277A (es) El uso del alendronato para preparar composiciones para reducir el riesgo de fracturas oseas no vertebrales.
PT832883E (pt) Compostos de tetrahidrobenzo(a)fluoreno e metodos de uso
KR970046824U (ko) 웨이퍼 플랫존 정렬장치
GR1002390B (el) Συστημα καλουπωματος δια ενα τοιχο με μανδυα απο μπετον.
IT240826Y1 (it) Calzatura per la pratica di uno sport per slittamento
FR2704129B1 (fr) Urinal individuel pour homme.
BR7502638U (pt) Tênis computadorizado
IT1278184B1 (it) Metodo per la realizzazione di suole per calzature
IT1281441B1 (it) Procedimento per la fabbricazione di scarpe
ITTO930166A0 (it) Procedimento per il trattamento di flussi reflui della produzione di n-fosfonometilglicina.
MX9604751A (es) Plantilla.